x
Advancing precision oncology through automated, high-purity single cell capture.
1Cell SOLO changes this by enabling the capture and analysis of intact, viable single cells—powered by AI and advanced microfluidics. Whether used for research, clinical diagnostics, or drug development, Solo delivers unmatched resolution, accuracy, and efficiency.
True single cell resolution for precise tumor and biomarker profiling
AI-driven selection ensures high-purity and reproducible results
Fully automated, reducing manual handling and contamination risk
Scalable, high-throughput processing for clinical and research settings
Seamlessly integrates into single cell sequencing and multi-omics workflows
Solo captures intact, live tumor cells from biological samples using advanced microfluidics.
Proprietary AI algorithms identify and isolate viable tumor cells, eliminating non-target cells and impurities.
The system delivers single cells compatible with downstream genomic, transcriptomic, and proteomic analysis.
Solo is designed to handle multiple samples simultaneously, minimizing hands-on time while maximizing output.
Single-cell sequencing for deep genomic insights
Targeted biomarker discovery
Accelerated drug development and screening
Identifying rare cell populations and tumor heterogeneity
Supporting precision oncology decisions
Enabling early detection and longitudinal disease monitoring